Apply for a grant

Open competition grants



LEO Foundation ‘Open competition grants’ are given to support the best dermatology research projects worldwide. Thus, we welcome applications from research projects that:

  • Improve the understanding of the underlying medicinal, biological, chemical, or pharmacological mechanisms of dermatological diseases and their symptoms
  • Address clinical issues among people who are at risk of developing, or have developed, a skin disease, including how it impacts their quality of life and the societal costs involved.

The LEO Foundation’s Board of Trustees has established a formal evaluation process with a panel of national and international external experts to assist the Board in ensuring that our grants are given to the best projects and the most qualified applicants.

The LEO Foundation requests that results from the research funded by the Foundation are shared with the public, patients and healthcare professionals – for example through publication in peer-reviewed journals, oral presentations, or public awareness campaigns.


 Application procedure


  • Download the “Application Guide”, the “Application Form” and the “Budget Template” from “Download & views” section above to the right
  • Read the guide and fill in the application form and the budget template accordingly, using English language, ensuring that all mandatory fields are filled in, and that you comply with our guidelines
  • Send the application as a single PDF to (you will receive an initial confirmation that we have received it)
  • Once the current deadline is reached, your application is screened for mandatory requirements and if approved, assigned a designated ID to be used for all future communication. It is then evaluated by the LEO Foundation Scientific Evaluation Committee (SEC) (see the members below) using the criteria and scoring guide shown in the Application Guide here
  • Based on the evaluations by the Scientific Evaluation Committee the LEO Foundation Board of Trustees approves allocation of all grants. If and when approved, you will be notified, and your project is assigned a dedicated contact person
  • All applicants receive an answer to their application, sent by e-mail. The Foundation does not provide arguments as to why an application has been rejected, but provides a few statistics about the application round
  • A list of awarded grants including names of the recipients and project titles are published here

Scientific Evaluation Committee (SEC)

The LEO Foundation has appointed an independent Scientific Evaluation Committee (SEC) for evaluation of applications received in open competition. Our SEC has the following members:

  • Professor Piet H. van der Graaf, PharmD, PhD, Senior Vice President Certara (United Kingdom) and Department of Systems Pharmacology Leiden University (The Netherlands)
  • Professor Rune Hartmann, PhD, Department Molecular Biology and Genetics, Aarhus University (Denmark)
  • Professor David Roblin, MD, FRCP, FFPM, FMedSc, President of R&D, Summit Therapeutics Chair of Scientific Translation, The Francis Crick Institute (United Kingdom)
  • Professor Carsten Bindslev-Jensen, MD, DMSc, PhD, Department of Clinical Allergology, Odense University Hospital Svendborg (Denmark)
  • Associate Professor Liv Eidsmo, MD PhD,  Department of Medicine, Karolinska Institutet (Sweden)
  • Associate Professor Amanda MacLeod, MD, Associate Residency Program Director for Research, Department of Dermatology, Duke University School of Medicine (USA)

All applications are administratively screened for formal requirements. The applications that are accepted undergo SEC review according to the criteria and scoring guide shown in the Application Guide here.
Each designated SEC member submit an individual evaluation to the LEO Foundation and following consolidation of the input from the SEC members, the Foundation’s Board of Trustees makes the final decision.


 Not eligible for support are costs related to


  • Graduate students and/or academic fees except Ph.D. tuition fees
  • Administration or overhead costs exceeding 5 %
  • Participation in domestic meetings or courses
  • Passive attendance at conferences
  • Travel by several persons from the same research unit or department
  • Expenses incurred prior to making an application or obtaining a grant
  • Research projects involving commercial companies
  • Research projects involving commercial drug testing
  • Clinical trials and register-based studies testing medical compounds
  • Moreover, applications from other foundations or associations, applications that are not submitted online, or applications that are not in compliance with our application guidance are not eligible for support